Treating aged WT or adult Sod1−/− mice with necrostatin-1s, a RIPK1 inhibitor, reduces liver inflammation and MASH pathology, underscoring the necroptosis pathway’s role in age-related liver inflammation and MASH. This evidence concerns the gene RIPK1 and inflammation.